Temporal interference stimulation for nicotine vaping addiction
Official title: Temporal Interference Methods for Addiction Treatment
Run by Indiana University · NCT07210268 · Data updated 2026-11-12
This trial will test whether a non-invasive brain stimulation method called temporal interference can lower cravings and reduce vaping in adults who use nicotine.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 50 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Indiana University Academic / other |
| Locations | 2 sites (Bloomington, Indiana and 1 other locations) |
| Status | Recruiting |
| Started | January 22, 2026 |
| Main results expected | February 20, 2027 |
| Study ends | February 27, 2027 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07210268 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 21–50 who are nicotine-dependent vapers (≥15 mg nicotine per day), can read English, have a phone with internet access, and can abstain from nicotine for at least 8 hours are the intended participants.
✕Probably not a fit
People with a history of seizures, active severe psychiatric or neurological disorders, significant cardiac problems, or active use of opioids, cocaine, or methamphetamine are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, placebo-controlled trial will enroll 120–150 nicotine-dependent adults who vape and randomize them to TI targeting the nucleus accumbens, TI targeting the anterior insula, or a sham condition. After at least 8 hours of nicotine abstinence, participants will undergo a single 60-minute stimulation session while using a custom vape device that records real-time inhalation and provide craving ratings during and after stimulation, with use monitored for one week. Temporal interference delivers intersecting high-frequency scalp currents that create a low-frequency envelope aimed at stimulating deep brain regions without surgery, and prior pilot work has shown TI can activate the nucleus accumbens on fMRI. The trial compares whether stimulation of the insula or nucleus accumbens reduces craving and nicotine inhalation more than sham.
Why it matters
Potential benefit: If successful, TI could offer a non-surgical way to rapidly reduce nicotine craving and vaping, potentially expanding treatment options for people who vape.
How similar studies have gone: Invasive deep brain stimulation of the nucleus accumbens and insula has produced strong reductions in addictive behavior in case reports, and pilot TI work shows target activation on fMRI, but TI for addiction remains novel and not yet proven in larger clinical trials.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Between the ages of 21 and 50 * Nicotine dependent and vape at least 15 mg nicotine per day * Must have a phone with internet access * Participants must have at least a 6th grade education and be able to speak and read English Exclusion Criteria: * History of seizures, seizure disorders, or familial history of seizure disorders * History of intractable migraine or complicated migraine syndromes * History of suicide attempts or active suicidal ideation (past month) * History of cardiac arrhythmias, prolonged QT, pacemakers, or cardiovascular disorders * Hypertension with systolic BP \>150mmHgCentral nervous system structural lesions (tumors, MS, strokes, etc.) * Active neuropsychiatric disorders (schizophrenia, bipolar, active psychosis, dementia, etc.) * History of head trauma with loss of consciousness, skull fractures, subdural hematomas * Active opioid, cocaine, and/or methamphetamine use * Active severe cannabis use disorder * Active alcohol use disorder or history of alcohol withdrawal * Metal implants in the head or under the scalp (excluding dental implants) * Current smoking cessation treatment or medications affecting reward processing * Pregnancy
Where it's running
-
Indiana University
Bloomington, Indiana, United States Recruiting -
Indiana University School of Medicine - Goodman Hall
Indianapolis, Indiana, United States Recruiting
Study contacts
- Principal investigator: Joshua Brown — Indiana University, Bloomington
- Study coordinator: Joshua Brown, PhD
- Email: cclab@iu.edu
- Phone: 812-855-9282
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
tDCS plus varenicline to help people quit smoking
This will test if adding noninvasive tDCS brain stimulation to varenicline helps adults who smoke at least 8 cigarettes a day quit and stay smoke-free.
-
Impact of Menstrual Cycle Phase on Smoking Cessation
This study tests if starting smoking cessation treatment during certain phases of the menstrual cycle helps women quit smoking more successfully.
-
Interprofessional Training to Improve Care for Peri-Delivery Patients with Substance Use Disorder
This program tests INSPIRE, a set of online and in-person trainings for healthcare teams to reduce stigma and improve care for people with substance use disorder around labor, delivery, and postpartum at the University of Utah.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Interdisciplinary support to smooth care transitions for hospitalized adults with substance use disorders
This study tests a team-based in-hospital and post-discharge program to help adults with substance use disorders move from hospital care to ongoing community treatment.
-
Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice (MISSION-CJ) for re-entry
This trial tests a multicomponent program called MISSION-CJ with Peer Linkage Support to help adults released from two Massachusetts jails who have both mental health and substance use disorders.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.